1. Introduction
Worldwide, there is dissatisfaction with current, input-oriented and supply-led health care systems. These systems are characterised by monodisciplinary and segmented care and result in fragmented care processes, suboptimal quality and waste of resources (Porter & Teisberg, Reference Porter and Teisberg2006; Berwick, Reference Berwick2011; De Bakker et al., Reference De Bakker, Struijs, Baan, Raams, de Wildt, Vrijhoef and Schut2012; Mechanic & Tompkins, Reference Mechanic and Tompkins2012; Pronovost, Reference Pronovost2013; Tsiachristas, Reference Tsiachristas2015). There is consensus that flawed provider payment methods contribute to this problem (McGuire, Reference McGuire2000; Porter & Teisberg, Reference Porter and Teisberg2006; McGuire, Reference McGuire2011). In particular, predominant payment methods generate perverse incentives for health care providers regarding the delivery of services. For example, fee-for-service (FFS) – in which providers are paid retrospectively for each service delivered – is still a very common payment method in health care (especially in the United States) because it is relatively easy to administer and encourages productivity (Jegers et al., Reference Jegers, Kesteloot, de Graeve and Gilles2002; Marmor et al., Reference Marmor, Oberlander and White2011). However, this payment method may generate a ‘more-is-better culture’ and therefore tends to overprovision. In addition, providers who promote population health and successfully prevent treatment are financially penalised for that (Jegers et al., Reference Jegers, Kesteloot, de Graeve and Gilles2002; Ellis & Miller, Reference Ellis and Miller2008). Another widespread payment method (especially in Europe) is capitation, in which providers receive a fixed amount per person per period. This payment method also has important drawbacks, such as encouraging underprovision and risk selection (Porter & Kaplan, Reference Porter and Kaplan2016). Furthermore, both FFS and capitation (as well as other predominant payment methods) do not reward the provision of high-quality care and innovation. Finally, because these methods traditionally remunerate single, monodisciplinary providers instead of multidisciplinary groups of providers, they preserve fragmentation and thwart cooperation and coordination across the continuum of care (Epping-Jordan et al., Reference Epping-Jordan, Pruitt, Bengoa and Wagner2004; Van Exel et al., Reference Van Exel, Koopmanschap, Scholte op Reimer, Niessen and Huijsman2005). In short, predominant payment methods are not fully aligned with ‘value’.
In order to tackle the problems related to current payment methods, worldwide, policymakers and purchasers of care are exploring alternative payment strategies to help steering health care systems towards value (Conrad et al., Reference Conrad, Grembowski, Hernandez, Lau and Marcus-Smith2014; Burwell, Reference Burwell2015). A well-known endeavour in this regard is pay-for-performance (P4P), in which providers are explicitly rewarded for ‘doing a better job’. Although P4P is an appealing idea, explicit financial incentives for value should in principle be used only modestly in provider payment methods because of the multitasking problem (Holmstrom & Milgrom, Reference Holmstrom and Milgrom1991; see section 3.2).
Therefore, it is not surprising that in practice, the majority of provider revenues (typically referred to as the base payment) is not explicitly linked to value. This base payment, however, does create implicit (dis)incentives for value, because each payment method influences providers’ behaviour through incentives (Jensen & Meckling, Reference Jensen and Meckling1976; Enthoven, Reference Enthoven1988; Prendergast, Reference Prendergast1999; McGuire, Reference McGuire2000; Gaynor et al., Reference Gaynor, Rebitzer and Taylor2004; Berenson, Reference Berenson2010; Christianson & Conrad, Reference Christianson and Conrad2011; McGuire, Reference McGuire2011). In this paper, we underline the importance of carefully considering the design of particularly these implicit financial incentives, in such a manner that desired behaviour is fostered and value is incentivised. We discuss a theoretically preferred design of a payment method that both implicitly and explicitly stimulates value in a broad sense, henceforth referred to as value-based payment (VBP).
There is substantial literature on the theory and implementation of payment incentives (for an overview, see McGuire, Reference McGuire2000; McGuire, Reference McGuire2011; Conrad et al., Reference Conrad, Grembowski, Hernandez, Lau and Marcus-Smith2014; Conrad, Reference Conrad2015; Conrad et al., Reference Conrad, Vaughn, Grembowski and Marcus-Smith2016). However, the theoretical basis of VBP design is fragmented and in the available work, the terms ‘value’ and ‘VBP’ are often implicitly used for different dimensions of value. In addition, the relationship between what a health care system ideally pursues in terms of value and what is required in terms of the VBP design to achieve this has not been explicated. Therefore, this paper aims at: (1) identifying key-value dimensions that are ideally stimulated by VBP and (2) constructing a conceptual framework of a theoretically preferred VBP design according to these dimensions. We achieve these goals based on a synthesis of findings of key theoretical and empirical studies conducted in the field of health services research, health economics, contract theory and the general economic theory on incentive design. Throughout, we relate our findings to VBP initiatives from practice, and end with illustrating some important trade-offs in the practical operationalisation of VBP. The insights from this paper are of practical relevance for policymakers and purchasers who are responsible for (re)designing existing and future VBP initiatives.
The structure of this paper is as follows. In the next section, key-value dimensions are discussed, followed by a section containing a concise theoretical background on payment methods. The fourth section focusses on a theoretically preferred VBP design. Section 5 illustrates several important trade-offs in the practical operationalisation of VBP, followed by some concluding remarks.
2. Key-value dimensions in health care
In previous work, the term ‘value’ in health care has been defined in different ways. According to the Institute of Medicine (IOM, 2001), health care needs to be safe, effective, patient-centred, timely, efficient and equitable. Berwick et al. (Reference Berwick, Nolan and Whittington2008) state that a health care system should pursue a Triple Aim of limiting per capita cost of care, improving individual patient experience and improving population health. Porter (Reference Porter2009, Reference Porter2010) provides a more global description of health care system goals, namely maximal value, defined as the best health outcomes achieved per dollar spent. Value encompasses efficiency and the central focus is on multidimensional outcomes, rather than inputs and processes. Conrad (Reference Conrad2015) defines value as maximum health benefit (i.e. health outcomes, processes of care and patient experience) at minimum cost.
Based on these descriptions as well as arguments derived from the societal debate on what stakeholders in health care should ideally aim for (Eijkenaar & Schut, Reference Eijkenaar and Schut2015), five key-value dimensions can be distinguished:
1. High-quality care. Care is safe, effective, patient-centred and timely. High quality comprises ‘technical’ or clinical quality as well as patient-reported measures regarding individual care paths and outcomes (e.g. PROMs). Technical quality can be operationalised in structures (e.g. having an up-to-date patient registry for diabetes patients affiliated with the primary care practice), processes (e.g. regularly checking the blood glucose levels of diabetes patients) and (intermediate) outcomes (e.g. acceptable blood sugar levels for diabetes patients or absence of diabetes-related complications) (Donabedian, Reference Donabedian1988).
2. Cost-conscious behaviour. Scarce resources are efficiently used, so there is no misuse or overuse.
3. Well-coordinated care. Multidisciplinary providers communicate and cooperate well in order to realise integrated, well-orchestrated care across the continuum of care. This dimension mainly regards coordination between providers of different disciplines and sites. A team-based approach in which multidisciplinary providers work side-by-side is of great importance, particularly given the increase in the number of individuals with multiple (chronic) diseases.
4. Cost-effective innovation. Cost-saving services result in equal or better health and health-promoting innovations are worth the additional costs.
5. Cost-effective prevention. Deteriorations of health problems are prevented in a cost-effective way. This dimension entails primary, secondary and tertiary prevention.
In this paper, a payment method is considered ‘value-based’ if it simultaneously provides incentives for all dimensions. Clearly, these dimensions are interrelated. For instance, well-coordinated care can be considered an element of high-quality care. However, for the purpose of describing a theoretically preferred VBP design, it is necessary to explicitly distinguish the different dimensions of value. Note, however, that it is not the goal of this paper to develop indicators for measuring value. As we will argue below (Section 3.2), the measurement of all aspects of value and calculating payments only based on indicator scores is neither feasible nor desirable.
3. Theoretical background on provider payment methods
3.1 Financial incentives to counterbalance agency problems
Agency theory, as part of contract theory, studies the relation between two contracting parties: the principal and the agent (Spence & Zeckhauser, Reference Spence and Zeckhauser1971; Ross, Reference Ross1973). In this paper, the focus is on the health care provider acting as a double agent, interacting with both the patient and the purchaser (Blomqvist, Reference Blomqvist1991). Information asymmetry between providers as the relatively well-informed party relative to patients and purchasers is not a problem, as long as the interests of all involved parties are aligned (Laffont & Martimort, Reference Laffont and Martimort2002). However, in case of conflicting interests, agency problems may evolve and providers may exploit their information surplus for their own (financial) benefit (Jensen & Meckling, Reference Jensen and Meckling1976; Richardson, Reference Richardson1981).
An important strategy to counterbalance agency problems entails ‘controlling’ the agent by means of (financial) incentives (Vermaas, Reference Vermaas2006). The goal of controlling is to align providers’ interests with those of patients’ and ‘purchasers’ and is based on the assumption that providers are in the position to improve value if they are motivated to do so. Providers’ responsiveness to financial incentives has been well documented in the literature, implying that the (design of the) payment method is an important factor influencing providers’ behaviour and can thus be used to help steering health care systems towards value (Jensen & Meckling, Reference Jensen and Meckling1976; Enthoven, Reference Enthoven1988; Prendergast, Reference Prendergast1999; McGuire, Reference McGuire2000; Gaynor et al., Reference Gaynor, Rebitzer and Taylor2004; Berenson, Reference Berenson2010; McGuire, Reference McGuire2011).
3.2 The need for a base payment
Ideally, providers who are ‘doing a good job’ in terms of key-value dimensions are explicitly rewarded for this. A prerequisite of a payment method based fully on providers’ performance with respect to value is that all aspects of value can be captured in the payment contract (i.e. for each aspect an indicator is available on which providers can be ‘scored’). Complete contracts are, however, unfeasible in health care since the outcomes of some of the multiple tasks that providers perform, are more difficult (or even impossible) to measure objectively than others. For instance, for some medical interventions reliable and valid outcome indicators are available, whereas for other care activities – e.g. good communication and coordination of care – the added value is difficult to measure and appropriate registries are lacking. This problem has been referred to as the multitasking problem (Holmstrom and Milgrom, Reference Holmstrom and Milgrom1991; Eggleston, Reference Eggleston2005; Frølich et al., Reference Frølich, Talavera, Broadhead and Dudley2007) and is defined as the challenge of designing incentives to motivate appropriate effort across multiple tasks when the desired outcomes for some tasks are more difficult to measure than others (Eggleston, Reference Eggleston2005). An important potential consequence of this challenge is that explicitly rewarding providers for some specific aspects of value may result in undesired behaviour. Specifically, providers may focus disproportionately on those tasks that are measured and rewarded and neglect unincentivised tasks. This phenomenon has been referred to as ‘teaching to the test’ (Holmstrom & Milgrom, Reference Holmstrom and Milgrom1991) and has actually been observed in practice (Steel et al., Reference Steel, Maisey, Clark, Fleetcroft and Howe2007; Glickman et al., Reference Glickman, Ou, DeLong, Roe, Lytle, Mulgund, Rumsfeld, Gibler, Ohman, Schulman and Peterson2007; Campbell et al., Reference Campbell, Reeves, Kontopantelis, Sibbald and Roland2009; Mullen et al., Reference Mullen, Frank and Rosenthal2010).
Due to the multitasking problem and the associated risk of teaching to the test, explicit financial incentives for value can and should be used only modestly in provider payment methods. As a consequence, the majority of providers’ revenues can and should not be explicitly related to value. This part of providers’ revenue is commonly referred to as the base payment. This base payment will typically comprise the largest part of total provider payment, whereas the payment component explicitly related to performance indicators (P4P) is likely to be relatively small. Indeed in practice, base payments currently comprise at least 90% of total provider payment (Eijkenaar, Reference Eijkenaar2013; Ryan et al., Reference Ryan, Shortell, Ramsay and Casalino2015; Milstein & Schreyögg, Reference Milstein and Schreyögg2016). So far, papers investigating VBP reform have focussed mainly on the design of the relatively small P4P component. Being the largest payment component, however, the design of the base payment is at least equally and arguably more important.
3.3 Shortcomings of predominant and alternative base payment methods
The four most frequently applied base payment methods in practice are payment per item-of-service (FFS), payment per case (e.g. DRG’s), payment per person (capitation) and payment per period (salary for individual providers and fixed budget for organisations). In Table 1, the incentives generated by these methods in relation to the key-value dimensions are summarised, based on Jegers et al. (Reference Jegers, Kesteloot, de Graeve and Gilles2002), Ellis & Miller (Reference Ellis and Miller2008) and Christianson & Conrad (Reference Christianson and Conrad2011). This table shows that, although each payment method to some extent stimulates at least one key-value dimension, other dimensions are not incentivised or even discouraged.
Base payment methods and their incentives for key-value dimensionsFootnote a
FFS=fee-for-service.
a Authors’ own analysis.
b By definition, no incentives for well-coordinated care exist because in these examples the payment is assumed to apply to a single, monodisciplinary provider.
As none of the predominant base payment methods adequately promotes all key-value dimensions, alternative base payment methods have been developed. One example is combining predominant methods with opposing incentives in order to sustain the favourable elements of each method, while neutralising the drawbacks (Ellis & McGuire, Reference Ellis and McGuire1986; Robinson, Reference Robinson2001; Christianson & Conrad, Reference Christianson and Conrad2011; McGuire, Reference McGuire2011). Unfortunately, it is still unlikely that all value dimensions are stimulated under these mixtures (see Table 1, for a mixed payment method of 50% FFS and 50% capitation). Another recent example of an alternative base payment method is bundled or episode-based payment (De Brantes et al., Reference De Brantes, Rosenthal and Painter2009; Mechanic & Altman, Reference Mechanic and Altman2009; De Bakker et al., Reference De Bakker, Struijs, Baan, Raams, de Wildt, Vrijhoef and Schut2012; Ridgely et al., Reference Ridgely, de Vries, Bozic and Hussey2014). Although bundling stimulates cost-conscious behaviour and well-coordinated care, value is only stimulated to some extent and only for those services inside the bundle (Wilensky, Reference Wilensky2014; Table 1).
4 A theoretically preferred VBP design
4.1 Core components of a theoretically preferred VBP
Building on the theory as discussed in Section 3, a theoretically preferred VBP should consist of two core components: (1) a substantial base payment that implicitly stimulates key-value dimensions and (2) a relatively small variable payment that explicitly rewards some measurable aspects of value dimensions (P4P). A base payment is a vital component of a theoretically preferred VBP because of the multitasking problem and the risk of teaching to the test when using high-powered explicit incentives (Section 3.2). Nevertheless, relatively small explicit rewards are a crucial component of a theoretically preferred VBP. This payment component is required to ensure that value aspects that are not or cannot be implicitly incentivised by the base payment, are given sufficient attention by providers. The variable payment is particularly suitable for stimulating aspects of value that can be relatively easily and objectively measured and that are difficult to incentivise implicitly (Vlaanderen et al., Reference Vlaanderen, Tanke, Bloem, Faber, Eijkenaar, Schut and Jeurissen2018). Typically, these aspects are related to the value dimension ‘high-quality care’ since a broad spectrum of indicators has already been developed and is increasingly becoming available as a result of an increasing number of P4P-experiments and initiatives employed by the International Consortium for Health Outcomes Measurement (ICHOM). Other measurable aspects of other value dimensions, however, can be part of the variable payment as well (e.g. smoking cessation counselling as an element of cost-effective prevention; Lindenauer et al., Reference Glickman, Ou, DeLong, Roe, Lytle, Mulgund, Rumsfeld, Gibler, Ohman, Schulman and Peterson2007; Mendelson et al., Reference Leijten, Struckmann, van Ginneken, Czypionka, Krauss, Reiss, Tsiachristas, Boland, de Bont, Bal, Busse and Rutten-van Mölken2017).
The two components should be well tailored to ensure every value dimensions is implicitly and/or explicitly incentivised by VBP. The variable payment can be either designed as an ‘add-on’ to the base payment or as an integral part. The first modality is similar to most current P4P-programs, while in the latter modality receiving (part of) the base payment is conditional on meeting specific value targets. Note that the relative shares of the two components may vary over time and may depend heavily on the specific context (see Section 5). For instance, if better performance indicators become available, the share of the variable component that explicitly rewards high quality may increase relative to the base component.
In practice, there are several payment methods that come close to the theoretically preferred VBP design as described above. Box 1 provides a description of three prominent examples. In the remainder of this paper, we relate our findings to these examples.
VBP practice initiatives.
Henceforth, we focus on the first component of a theoretically preferred VBP – the base payment – for two reasons. First, the design of the second component – the variable payment – has already been extensively discussed in the literature (for an overview, see Eijkenaar, Reference Eijkenaar2013; Milstein & Schreyögg, Reference Milstein and Schreyögg2016). Second, as argued above, the base payment typically comprises the majority of providers’ revenues, underlining the importance of carefully designing the implicit incentives generated by this component.
4.2 Five key features of a theoretically preferred base payment
Below, we explain which key features of a theoretically preferred base payment are required to stimulate value in a broad sense. Based on a synthesis of the findings of key studies conducted in the field of health services research, health economics, contract theory and the general economic theory on incentive design, we conclude that the base payment should preferably be paid (1) to a multidisciplinary provider group for delivering (2) a cohesive set of care activities to a predefined population. In addition, the base payment should (3) be fixed, (4) be adjusted for the population’s risk profile and (5) include risk-mitigating measures. We acknowledge that these five key features are interrelated (e.g. for the provision of a comprehensive set of care activities a multidisciplinary provider group is required).
4.2.1 Multidisciplinary provider group
To encourage well-coordinated care, the base payment should jointly remunerate multidisciplinary groups of providers who have agreed to work together as an ‘accountable group’ for the delivery of a cohesive set of care activities. Depending on the exact nature of the care activities, these groups may consist of different types of physicians (e.g. primary care physicians or medical specialists), other health care professionals (e.g. nurses or physiotherapists) and various care facilities (e.g. specialty hospitals or rehabilitation centres).
Financial barriers between separately paid providers are removed once a single, integrated payment for a provider group is introduced. Such an integrated payment to a provider team is expected to encourage multidisciplinary cooperation and collaboration, fostering greater (cross-specialty) coordination and increasing active provider engagement in improvements across the whole care path (Anderson & Weller, Reference Anderson and Weller1999; Berenson, Reference Berenson2010; Burwell, Reference Burwell2015; Mehrotra & Hussey, Reference Mehrotra and Hussey2015). This is of relevance particularly for the increasing number of individuals with multiple co-existing (chronic) health problems who will likely benefit from well-coordinated, integrated care (DeGruy & Etz, Reference DeGruy and Etz2010; Pollack et al., Reference Pollack, Raney and Vanderlip2012; Leijten et al., Reference Leijten, Struckmann, van Ginneken, Czypionka, Krauss, Reiss, Tsiachristas, Boland, de Bont, Bal, Busse and Rutten-van Mölken2017). In addition, paying a provider group instead of individual providers is likely to result in more flexibility in the use of resources (Mechanic & Altman, Reference Mechanic and Altman2009; Miller, Reference Miller2009; Cutler & Ghosh, Reference Cutler and Ghosh2012; Tsiachristas et al., Reference Tsiachristas, Dikkers, Boland and Rutten-van Molken2013). Another advantage is that the financial risk that is associated with VBP is pooled. This may prevent individual providers from being confronted with excessive financial risk and may reduce incentives for undesired behaviour (Anderson & Weller, Reference Anderson and Weller1999; Gaynor et al., Reference Gaynor, Rebitzer and Taylor2004; Vermaas, Reference Vermaas2006; Frakt & Mayes, Reference Frakt and Mayes2012).
Group-based incentives require a certain entity that contracts with the purchaser and receives the payment on behalf of the provider group. This ‘main contracting entity’ administers the payment and is responsible for the organisation, coordination and (possibly) the delivery of care activities and employs or subcontracts other providers (Anderson & Weller, Reference Anderson and Weller1999). The main contractor thus initially bears the financial risk and has to divide the pain and gain among the group members. Entities such as ACOs, health maintenance organisations (HMOs) and hospitals might qualify for this role because of their size and level of professionalism. To pass the incentives along from the group to the individual providers, a transparent payment distribution mechanism needs to be developed; it has to be decided ‘who is getting paid, how much, for doing what’ (Frølich et al., Reference Frølich, Talavera, Broadhead and Dudley2007). For instance, distribution can be in proportion to the provider’s share of the target population or the provider’s contribution to the group’s performance (Olson, Reference Olson1965; Gaynor et al., Reference Gaynor, Rebitzer and Taylor2004; Conrad, Reference Conrad2015).
4.2.2 Cohesive set of care activities for a predefined population
To encourage cost-effective prevention, the base payment should remunerate a provider group for the provision of a cohesive set of (preventive) care activities to a predefined population of individuals. From a theoretical perspective, VBP ideally involves ‘whole-person accountability’. Key to such an approach is that the payment is not disease-specific but person-centred and holistic. The payment covers all relevant health services given a person’s needs. An evident set of care activities that is covered by the payment is (virtually) the full continuum of services included in the relevant benefit package in place. For instance, if a provider group accepts whole-person accountability for a target population of diabetics, the provider group is not only responsible for all diabetes-related care but for all care services that the diabetics in the target population might need, within limitations of the relevant benefit package covered by the health plan or other third party payer. The target population may consist of any defined set of individuals, including those not currently in need of care (Kindig, Reference Kindig2007).
Whole-person accountability triggers incentives for health promotion and prevention because prevention is often more effective and cheaper than cure. The more a provider group improves the health of the population, the greater the financial gain (Sharfstein, Reference Sharfstein2016). Stimulating preventive efforts is of great importance, since the causes of many health problems lie in individual behaviour (e.g. smoking and unhealthy diet) and the current system does not effectively promote healthy behaviour (Berwick et al., Reference Berwick, Nolan and Whittington2008; Casalino et al., Reference Casalino, Erb, Joshi and Shortell2015). Another advantage of a whole-person accountability approach is that effective long-term management of chronic diseases (e.g. delaying the progression of diseases and preventing exacerbations) is stimulated (Berenson, Reference Berenson2010; McClellan et al., Reference McClellan, Kent, Beales, Macdonell, Thoumi and Shuttleworth2013; Conrad, Reference Conrad2015). In addition, cost-shifting becomes more difficult once the payment applies to a broad set of care activities and is even impossible if the payment applies to all care services (Sood, Reference Sood2011; Busse & Stahl, Reference Busse and Stahl2014). The provision of unnecessary services is expected to gradually be phased out (Gaynor et al., Reference Gaynor, Rebitzer and Taylor2004; McClellan et al., Reference McClellan, Kent, Beales, Macdonell, Thoumi and Shuttleworth2013). Finally, the risk of double payment for the same services decreases. Double payment is plausible in particular for patients with comorbidity and if services are paid for through different systems (Hussey et al., Reference Hussey, Ridgely and Rosenthal2011; EIB, 2012; Ridgely et al., Reference Ridgely, de Vries, Bozic and Hussey2014).
Four characteristics can be used to delineate the target population: (1) individual characteristics (e.g. age or diagnoses), (2) geographical catchment areas (e.g. region or ZIP-codes), (3) provider affiliation (e.g. enrolment in a GP practice or retrospective assignment to a provider based on actual utilisation) and (4) purchaser affiliation (e.g. having an insurance policy with a specific insurer). The characteristics are not mutually exclusive. Under the AQC (Box 1), the target population consists of individuals who are below 65 years of age, live in Massachusetts, are registered with a primary health care provider, and have an HMO or preferred provider organisation (PPO) insurance policy from BCBS (Mechanic & Altman, Reference Mechanic and Altman2009; Chernew et al., Reference Chernew, Mechanic, Landon and Safran2011; Song et al., Reference Song, Safran, Landon, Landrum, He, Mechanic, Day and Chernew2012; Song, Reference Song.2014). Assignment of the target population to the provider group for the coming year can be done prospectively (e.g. based on enrolment with affiliated primary care physicians, or on health care utilisation in the prior year) or retrospectively (e.g. based on the plurality of utilisation in the completed year). In case of prospective assignment, provider groups know beforehand for whom they are responsible in the coming year, enabling providers to proactively reach out to and improve care for their target population (Lewis et al., Reference Lewis, McGlurg, Smith, Fisher and Bynum2013). A potential advantage of retrospective assignment is that it stimulates providers to manage costs and quality for all of their patients, instead of just the assigned population. However, professional ethics may effectively prevent that – under prospective assignment – providers will actually distinguish between assigned and unassigned patients in terms of (the quality of) provided services. Under the AQC, assignment is done prospectively, while under the MSSP a retrospective form is used (Box 1).
4.2.3 Fixed payment for a defined period of time
To encourage cost-conscious behaviour and cost-effective innovation, the base payment should be fixed for a defined period of time, implying that there is no link with actual costs (Anderson & Weller, Reference Anderson and Weller1999; Jegers et al., Reference Jegers, Kesteloot, de Graeve and Gilles2002). Such a method implies that (some of) the financial risk is transferred from the purchaser to the provider. The financial result is retrospectively determined by the difference between actual expenses and the prospectively defined, fixed payment (‘reconciliation’).
A fixed payment for a defined period of time is theoretically preferred over a variable payment because of the high potential for cost-conscious behaviour and cost-effective innovation. Because marginal benefits are zero, providers are stimulated to reduce costs and to reconsider the full care process (Jegers et al., Reference Jegers, Kesteloot, de Graeve and Gilles2002; Miller, Reference Miller2009; Cutler & Gosh, Reference Cutler and Ghosh2012; Conrad et al., Reference Conrad, Grembowski, Hernandez, Lau and Marcus-Smith2014; Conrad, Reference Conrad2015). Critically assessing care processes might also uncover room for substitution of relatively expensive for relatively inexpensive services or providers (Casalino, Reference Casalino2001). In addition, because the payment can be flexibly deployed, more attention can be paid to cost-effective, creative management of care (Anderson & Weller, Reference Anderson and Weller1999; McConnell et al., Reference McConnell, Chang, Cohen, Wallace, Chernew, Kautz, McCarty, McFarland, Wright and Smith2014). Note, however, that a fixed payment for a defined period of time also is a main feature of traditional capitation that was heavily criticised in the past for, amongst other things, triggering care rationing and threatening patient choice (Porter & Kaplan, Reference Porter and Kaplan2016). These drawbacks from traditional capitation can be addressed by adding a variable payment component guaranteeing high-quality care (see Section 4.1), by adopting adequate risk adjustment (see Section 4.2.4.) and by including arrangements to mitigate excessive financial risk (see Section 4.2.5).
Below, three design issues of a fixed payment for a defined period of time are discussed: setting the payment level, multiyear contracts and risk transfer.
4.2.3.1 Setting the payment level
In general, three methods for setting the fixed payment level can be discerned. A first method is based on historical expenses (Douven et al., Reference Douven, McGuire and McWilliams2015; Rose et al., Reference Rose, Zaslavsky and McWilliams2016). An advantage of this approach is that calculation is relatively straightforward. However, because the payment level is based on prior expenses, past inefficiencies are ‘buried’ in the payment (Newhouse et al., Reference Newhouse, Buntin and Chapman1997; Berenson, Reference Berenson2010). Moreover, providers have a perverse incentive to increase expenses in the years prior to the onset of the contract, in order to build up the historical expenses that lie at the basis of the payment level (Berenson, Reference Berenson2010; Chernew et al., Reference Chernew, Mechanic, Landon and Safran2011; Douven et al., Reference Douven, McGuire and McWilliams2015). A second approach is basing the payment on average expenses, for instance per relevant peer group or region (Newhouse et al., Reference Newhouse, Buntin and Chapman1997; Ellis & McGuire, Reference Ellis and McGuire1988). An advantage is that the payment is relatively easy to calculate and providers with higher than average expenses due to inefficiency are stimulated to reassess their delivery processes. However, providers with higher than average expenses as a result of a disproportionate amount of high-risk individuals in the target population are disadvantaged (Rose et al., Reference Rose, Zaslavsky and McWilliams2016). In this case, the payment level can be considered as unfair and inaccurate, calling for appropriate risk adjustment (Section 4.2.4). A third option is to base the payment on acceptable expenses (Newhouse et al., Reference Newhouse, Buntin and Chapman1997). In this case, the payment is set at a level that is sufficient to cover only those expenses generated in delivering medically necessary, cost-effective care (Van de Ven & Ellis, Reference Van de Ven and Ellis2000). Although this approach seems theoretically preferred, it is difficult to implement in practice, since selecting the ‘right’ care activities and putting a price upon each service is disputable or likely to be unfeasible. Regardless of the chosen method for setting the payment level, the absolute price is clearly of relevance too. The payment should at least be sufficient to cover (potential) resource costs and to make the provision of high-value care worthwhile for providers.
4.2.3.2 Multiyear contracts
Contracts in which the fixed payment level is specified can be expected to be incomplete on a range of variables due to the multitasking problem (Maskin & Tirole, Reference Maskin and Tirole1999; Hart, Reference Hart2003). In the case of incomplete contracts, a certain level of mutual trust between the purchaser and the provider group is vital. Multiyear contracts are a sign of mutual trust and prevent costly effort on ‘overwriting’ complex, short-term contracts (Marques & Berg, Reference Marques and Berg2011). Microeconomic theory suggests that long-term contracts produce more favourable effects as compared to short-term contracts. A multiyear contract is likely to stimulate innovation and prevention because, over the longer term, providers are more likely to reap the financial benefits of their investments (Silberberg, Reference Silberberg1990; Christianson & Conrad, Reference Christianson and Conrad2011; Shortell, Reference Shortell2013). On the other hand, providers and purchasers may also be hesitant to conclude multiyear payment contracts because of the concern about being locked into the contract. This calls for a certain level of flexibility in the contract to be able to adjust for inflation and unforeseen events (Chernew et al., Reference Chernew, Mechanic, Landon and Safran2011; Rose et al., Reference Rose, Zaslavsky and McWilliams2016). In practice, multiyear VBP contracts have evolved, such as the five-year AQC contracts (Box 1).
4.2.3.3 Risk transfer
An important consequence of a fixed base payment for a defined period of time is that (some of) the financial risk is transferred from the purchaser to the accountable provider group. Two types of risk may be transferred: insurance risk and performance risk. Insurance risk is the risk that is typically borne by the purchaser and concerns the random variation around the mean health care expenses. Performance risk is the systematic variation around the mean expected health care expenses due to providers acting as imperfect agents. This risk can be influenced by providers, as it directly relates to the clinical skills and the choices made by the provider (Vermaas, Reference Vermaas2006; De Brantes & Rastogi, Reference De Brantes and Rastogi2008; Miller, Reference Miller2009; Berenson, Reference Berenson2010).
Ideally, only performance risk is transferred to the provider group, whereas insurance risk remains with the purchaser (Porter & Kaplan, Reference Porter and Kaplan2016). After all, it is the typical function of a purchaser to deal with random variation by pooling risks, and transforming providers into insurers is not the goal of VBP. Because the target population of a provider group is likely to be smaller than the total number of individuals the purchaser is responsible for, the conditions of the law of the large numbers for effective risk pooling might not be sufficiently fulfilled. Therefore, the provider group might face substantial financial risk due to large random variation from the statistically expected result (Christianson & Conrad, Reference Christianson and Conrad2011; Van de Ven, Reference Van de Ven2014). In comparison to purchasers, providers have limited financial means at their disposal to compensate for this random variation. Transferring insurance risk to providers could encourage risk selection (Section 4.2.4) and, in extremis, providers might go bankrupt (Anderson & Weller, Reference Anderson and Weller1999; Vermaas, Reference Vermaas2006).
Unfortunately, it is practically unfeasible to split insurance risk and performance risk (Vermaas, Reference Vermaas2006). Often, unravelling the extent to which health outcomes are the result of chance or of providers acting as (im)perfect agents is virtually impossible. For instance, a lower incidence of diabetes-related health problems in the target population could be the result of a decrease of the number of individuals with obesity due to a successful government campaign to improve lifestyle, but could also stem from a provider’s successful effort in monitoring blood glucose levels. The first explanation is not necessarily linked to the provider’s performance, while the second cause refers to the provider acting as a good agent. While risk-splitting is thus not possible, distributing the financial risk among providers and the purchaser in such a way that providers bear some, but not all, of the risk may be a viable option (Frakt & Mayes, Reference Frakt and Mayes2012).
4.2.4 Risk adjustment
To prevent undesired behaviour that may thwart key-value dimensions, the base payment should be risk-adjusted. If the payment is not corrected for systematic variation in expenses due to differences in risk characteristics of the target population, incentives for risk selection evolve because then the financial result is partly determined by the risk composition of the population, rather than a mark of achievement. Providers would be unfairly penalised financially if they are responsible for a disproportionate amount of high-risk individuals rather than low-risk individuals. In this case, providers have a financial incentive for risk selection which is the practice of attracting low-risk individuals for which the payment exceeds expected expenses and/or avoiding high-risk individuals for which the opposite holds (Iezzoni, Reference Iezzoni2003; Sood, Reference Sood2011; Rose et al., Reference Rose, Zaslavsky and McWilliams2016). Risk selection is undesired because it may jeopardise quality, equal access and efficiency (Welch, Reference Welch1999; Jegers et al., Reference Jegers, Kesteloot, de Graeve and Gilles2002; Barros, Reference Barros2003). Several empirical studies provide evidence of risk selection by capitated provider groups (Newhouse & Byrne, Reference Newhouse and Byrne1988; Frank & Lave, Reference Frank and Lave1989; Newhouse, Reference Newhouse1989; Cutler & Zeckhauser, Reference Cutler and Zeckhauser1998; Altman et al., Reference Altman, Cutler and Zeckhauser2000; Dranove et al., Reference Dranove, Kessler, McClellan, M and Satterthwaite2003; Chang et al., Reference Chang, Lin and Aron2012; Hsieh et al., Reference Hsieh, Tsai, Mau and Chiu2016).
In case of fixed payments, provider groups may experience incentives for risk selection. Because of the relatively small size of target populations a small number of high-risk individuals may have a large impact on the global budget. Providers are in the position to be successful in risk selection. First, providers are particularly well equipped to effectively identify low-risk and high-risk individuals because they have information about the health status of their target population and they are professionally trained to assess this type of information. Second, providers have subtle tools for risk selection. For instance, a provider might advise a high-risk patient to switch to a different provider by suggesting that he or she would be better served elsewhere (Folland et al., Reference Folland, Goodman and Stano2013). Non-financial restraints, such as peer review and professional ethics, may however counteract incentives for providers to engage in risk selection (Eggleston, Reference Eggleston2000).
With risk adjustment predictable, systematic variation in expenses as a result of differences in risk characteristics of the population is recognised and accounted for. In this way, risk adjustment contributes to a fair allocation of payments and ensures that providers are willing to accept and serve high-risk individuals. Ideally, risk adjustment creates a level playing field for providers (Anderson & Weller, Reference Anderson and Weller1999; Iezzoni, Reference Iezzoni2003; McGuire, Reference McGuire2011; Ash & Ellis, Reference Ash and Ellis2012; Omachi et al., Reference Omachi, Gregorich, Eisner, Penaloza, Tolstykh, Yelin, Iribarren, Dudley and Blanc2013; Brilleman et al., Reference Brilleman, Gravelle, Hollinghurst, Purdy, Salisbury and Windmeijer2014; Rose et al., Reference Rose, Zaslavsky and McWilliams2016). In Gesundes Kinzigtal, the base payment equals the normative cost-level calculated using the German risk-adjustment model for health insurers, and ACO and AQC models use population risk-score software to adjust for differences in risk characteristics of the target population (Box 1). It is an interesting question to what extent existing risk-adjustment models – most of which were originally developed to adjust capitation payments for insurers – can be (adequately) used to adjust provider payments, taking account of differences between provider and insurer payment regarding incentives and tools for risk selection.
4.2.5 Arrangements to limit excessive financial risk
To prevent undesired behaviour that may thwart key-value dimensions, the base payment should include arrangements that effectively mitigate excessive financial risk for providers. As discussed before, providers accepting VBP share financial risk with the purchaser. Risk adjustment accounts for systematic, predictable variation in expenses. However, the majority of between-person variance is random and unpredictable (Van Vliet, Reference Van Vliet1992; Newhouse, Reference Newhouse1996; Ellis & McGuire, Reference Ellis and McGuire2007). This implies that, even in the unlikely case of perfect risk adjustment, providers still face significant residual financial risk. To protect providers against excessive financial risk, additional approaches to mitigate this risk are likely to be required. In principle, these arrangements are focussed on protecting providers against large, unpredictable, random losses (i.e. insurance risk). However, such arrangements could also include protection against predictable and systematic risk that is, for whatever reason, not corrected for by a risk-adjustment model. Note that risk-mitigating arrangements could be used not only to limit but also to (gradually) expand the financial risk a provider runs. Below, we elaborate on two main parameters that can be simultaneously used to bring the financial risk to appropriate levels.
4.2.5.1 Type of risk sharing
Two main types of risk contracts can be distinguished. Under a one-sided risk contract, providers that keep expenses below the global payment share in the savings with the purchaser. An advantage is that providers can get familiar to accepting financial ‘risk’ without sharing in the losses and, keeping all else constant, have less incentives for undesired behaviour such as risk selection (Berwick, Reference Berwick2011). Under a two-sided risk contract, providers share in the savings, but also in the losses if expenses exceed the global budget. Providers accepting two-sided risk qualify for higher shared savings rates (Berwick, Reference Berwick2011; Rose et al., Reference Rose, Zaslavsky and McWilliams2016). Theoretical and empirical evidence from the field of behavioural economics has shown that individuals tend to prefer avoiding losses to achieving equivalent gains (Kahneman & Tversky, Reference Kahneman and Tversky1979; McNeil et al., Reference McNeil, Pauker, Sox and Tversky1982), suggesting that a two-sided risk contract provides stronger incentives for value than a contract that includes rewards only (Berenson, Reference Berenson2010). However, incentives for undesired behaviour increase under a two-sided risk contract (assuming imperfect risk adjustment). In the MSSP, ACOs can opt for a one-sided or a two-sided risk contract while they are in their first two contract periods. After this period, they can only accept a two-sided risk contract (Berwick, Reference Berwick2011; Rose et al., Reference Rose, Zaslavsky and McWilliams2016).
In addition to one- and two-sided risk contracts, risk corridors and reinsurance can be used to bring financial risk to the appropriate level. Risk corridors protect against cumulative losses, because losses and gains are limited beyond a predefined acceptable range (Layton et al., Reference Layton, McGuire and Sinaiko2016). Reinsurance can be defined as ‘the insurance of contractual liabilities incurred under contracts of direct insurance or reinsurance’ (Carter, Reference Carter1983: 4). In the case of VBP, reinsurance would imply that providers are retrospectively reimbursed by the purchaser for some or all of the expenses of specific individuals from their population, based on prospectively determined conditions. Under the AQC, for example providers can buy reinsurance from BCBS or an external entity (Chernew et al., Reference Chernew, Mechanic, Landon and Safran2011). A variety of non-mutually exclusive reinsurance techniques exist, such as stop-loss contracts, proportional risk sharing and outlier risk sharing (e.g. Carter, Reference Carter1983; Von Eije, Reference Von Eije1989; Bovbjerg, Reference Bovbjerg1992; Van Barneveld et al., Reference Van Barneveld, Lamers, van Vliet and van de Ven1998; Anderson & Weller, Reference Anderson and Weller1999; Vermaas, Reference Vermaas2006; Miller, Reference Miller2009).
4.2.5.2 Extent of risk sharing
Under VBP, the main contractor (i.e. provider group) shares the financial risk with the purchaser. Thus, the provider group is typically liable for less than 100% of the financial result (Vermaas, Reference Vermaas2006; Frakt & Mayes, Reference Frakt and Mayes2012). The risk rate (i.e. the share of savings/losses the provider group is accountable for) should not be set too high in order to keep the risk manageable for the provider group and to prevent (strong) incentives for risk selection in the case of imperfect risk adjustment. However, this rate should not be set too low either, because then the incentives lack power to actually affect provider’s behaviour (Laffont & Tirole, Reference Laffont and Tirole1993; Gaynor et al., Reference Gaynor, Rebitzer and Taylor2004).
The risk rate ideally depends on several variables. A first factor concerns the size of the target population. Ceteris paribus, if the size of the population increases, the payment is expected to gain in stability due to the law of the large numbers, allowing higher risk rates. Second, it seems natural to increase the risk rate for primary relative to secondary care if a primary care group acts as main contractor, while the opposite may be preferred if a hospital accepts this role. Third, the diminishing marginal utility of income might be taken into account (Conrad & Perry, Reference Conrad and Perry2009). Under the AQC, the risk borne by the different groups of providers ranges from 50% to 100% and is periodically (re)negotiated between the provider group and BCBS (Chernew et al., Reference Chernew, Mechanic, Landon and Safran2011).
In addition to the risk rate, carve-outs can be used to influence the extent of risk sharing. Carve-outs mitigate the financial risk for providers by placing a portion of the risk outside the payment and contracting separately for this risk (Frank & McGuire, Reference Frank and McGuire1998). For VBP, this would imply that certain services, medical conditions or populations are excluded from the contract and are paid for on a separate basis, such as FFS. Consequently, providers are protected against the associated high expenses of these services, conditions or populations and the high costs that are associated with acquiring the needed expertise (Frank & McGuire, Reference Frank and McGuire1998). Examples of possible carve-outs are intensive care, organ transplantation, mental health or cancer care. Carve-outs may also be required if whole-person accountability is not (instantly) feasible from a practical point of view or for those care services for which risk adjustment is not or insufficiently attainable; carve-outs can be used as an interim measure to (temporarily) exclude certain care types from the payment.
5. Trade-offs in the operationalisation of the base payment
In Section 4, a theoretically preferred VBP design was discussed. We explained how the largest component of VBP – the base payment – should preferably be designed to incentivise value. When it comes to the practical operationalisation of the base payment, several inherent trade-offs arise, implying that no ‘one size fits all’ design exists that can optimally incentivise all key-value dimensions simultaneously. The practical operationalisation of the base payment and the extent to which the different value dimensions are incentivised, depend on three determinants: (1) compatibility of incentives, (2) preferences and (3) context. Below, these determinants are briefly discussed and illustrated.
5.1 Compatibility of incentives
Theory predicts that several key features of the base payment are likely to conflict to a certain extent. For instance, regarding the optimal composition and size of the provider group, stronger incentives for well-coordinated care must be traded-off against weaker incentives for cost-conscious behaviour. In order to be able to deliver (virtually) the full continuum of care and realise well-coordinated care, the provider group will have to be composed of many different types of providers. But, as the composition becomes more diverse, the size of the provider group is likely to increase as well. Consequently, the financial risk that is associated with VBP is necessarily spread over more providers within the group, reducing the financial incentives for individual providers and increasing incentives for free-rider behaviour (Gaynor & Gertler, Reference Gaynor and Gertler1995; Gaynor et al., Reference Gaynor, Rebitzer and Taylor2004; Town et al., Reference Town, Wholey, Kralewski and Dowd2004; Conrad, Reference Conrad2015).
Another example of a practical decision involving trade-offs is about the comprehensiveness of the set of activities a provider group is responsible for. If the payment covers a broader set of care activities, the payment moves towards ‘whole-person accountability’ and incentives for health promotion and (primary) prevention become stronger. However, given that perfect risk adjustment is practically unfeasible, a more comprehensive set of activities will also increase the incentives for risk selection. Hence, stronger incentives for cost-effective prevention should be weighed against stronger incentives for risk selection.
5.2 Preferences
In trading-off the different value dimensions, decision-makers should carefully weigh preferences for each dimension, taking full account of relevant (societal) interests. For instance, if in a country health care expenses are considered to be at an acceptable level, while quality is considered to be suboptimal, decision-makers may attach greater importance to incentives for high-quality care and compromise on the incentives for cost-conscious behaviour (under the assumption that higher quality is associated with higher expenses). In this case, the share of the variable payment may be expanded, whereas the financial risk for providers may be reduced. Alternatively, a country with escalating health care expenses and an inefficient health care system may choose to intensify incentives for cost-conscious behaviour by expanding the financial risk for providers, while accepting the possible negative consequences in terms of stronger incentives for risk selection.
5.3 Context
The context of implementation can have a major impact on the practical operationalisation of the base payment, implying that VBP should be structured in relation to the circumstances of time and place (Conrad et al., Reference Conrad, Vaughn, Grembowski and Marcus-Smith2016). The following four examples illustrate this. First, if limited individual-level data on population risk characteristics are routinely available, a base payment that requires sophisticated risk adjustment is unlikely to be practically feasible. Second, in a setting where providers still predominantly work in monodisciplinary ‘silos’, it might be problematic to find provider groups that are willing and able to accept whole-person accountability. Third, in a setting in which the IT-infrastructure is underdeveloped, it is unlikely that a multidisciplinary provider group is effectively able to share the information required to realise well-orchestrated, integrated care for the target population (Miller, Reference Miller2009; Berwick, Reference Berwick2011). Fourth, expanding the size and scope of providers groups covered by VBP may also affect market concentration and therefore may reduce consumer choice and workable competition. Therefore, in countries with a competitive health care system, the optimal size and scope of provider groups covered by VBP may be smaller than in countries with a more centralised health care system.
6 Concluding remarks
This paper has provided a conceptual framework of key components and design features of a theoretically preferred VBP method. We consider a provider payment method ‘value-based’ if it stimulates value in a broad sense, that is if it offers incentives for: (1) high-quality care, (2) cost-conscious behaviour, (3) well-coordinated care, (4) cost-effective innovation and (5) cost-effective prevention.
To our knowledge, this is the first paper in the provider payment literature with a prime focus on the design of such a VBP method, and in particular of arguably the most important component thereof: the base payment. Based on a synthesis of existing literature from a variety of fields, this paper provides insight in the contours of a theoretically preferred VBP method.
The main contribution of this paper is twofold. Inspired by the societal debate on what stakeholders in health care should ideally strive for, as well as by existing definitions of value, we first described and further specified the concept of value, facilitating the specification of requirements in the design of VBP. We conclude that, in this respect, value is ideally conceptualised as a multifaceted concept, comprising not only high quality of care at the lowest possible costs but also efficient cooperation, innovation and health promotion. Second, starting from these value dimensions, we derived various design features of a theoretically preferred VBP model. We conclude that in order to stimulate value in a broad sense, the payment should consist of two main components that must be carefully designed. The first component is a risk-adjusted global base payment with risk-sharing elements paid to a multidisciplinary provider group for the provision of (virtually) the full continuum of care to a certain population. The second component is a relatively low-powered variable payment that explicitly rewards aspects of value that can be adequately measured.
Although a well-designed VBP is clearly a necessary condition for realising value-based health care, we acknowledge that it is unlikely to be a sufficient condition. Non-financial mechanisms as well as organisational structures may be at least as important (Robinson, Reference Robinson2001; Christianson & Conrad, Reference Christianson and Conrad2011; Phipps-Taylor & Shortell, Reference Phipps-Taylor and Shortell2016). Furthermore, as explained above, the practical operationalisation and implementation of a well-designed VBP model should not be underestimated and be well tailored to the specific context. Nevertheless, several innovative payment initiatives in practice already come quite close to the theoretically preferred VBP-design described in this paper, indicating that this design can actually be implemented in various contexts. An interesting direction for future research would be gaining more insight in how a two-component model as described in this paper can be practically operationalised and successfully implemented given the relevant context, as well as in the short- and long-term effects of introducing such a model on different value dimensions.
Acknowledgements
Our sincere thanks to members and guests of the Risk Adjustment Network meeting 2016 in Berlin, participants of the ESHPM seminar series, Thomas McGuire and two anonymous referees for their helpful comments on earlier drafts of this paper.
Open access
